Skip to content

Identification of Psychoplastogenic Tropanes Lacking Muscarinic Activity

Hunter T. Warren, Winston L. Chow, Milan Chytil, Kurt Rasmussen, David E. Olson

Journal of Medicinal Chemistry July 9, 2024 DOI: 10.1021/acs.jmedchem.4c01204 via OpenAlex

Summary

AI-generated from the abstract

Tropane-containing small molecules such as scopolamine can promote neuronal growth (psychoplastogens) but also block all muscarinic receptor subtypes, causing unwanted anticholinergic side effects. Researchers conducted phenotypic structure-activity relationship studies on various tropane subclasses to separate these effects. They identified several novel tropanes that substantially increase cortical neuron growth while showing much weaker activity at all muscarinic receptor subtypes than scopolamine, suggesting that the neuroplasticity-promoting and muscarinic-blocking properties can be decoupled.

Study at a glance

Characteristics Phenotypic structure-activity relationship study Peer reviewed
Keywords Muscarinic acetylcholine receptor Identification biology Pharmacology Biochemistry Genetic neurodegenerative diseases
Citations 5
Key finding Novel tropanes were found that promote cortical neuronal growth with drastically reduced muscarinic receptor activity compared to scopolamine.

Abstract

Tropane-containing small molecules like scopolamine are a promising class of psychoplastogens. However, their potent antagonism of all muscarinic receptor subtypes presents the potential for undesirable anticholinergic side effects. In an effort to decouple their neuroplasticity-promoting effects from their muscarinic activity, we performed phenotypic structure-activity relationship studies across a variety of structurally distinct subclasses of tropanes. We discovered several novel tropanes capable of significantly increasing cortical neuronal growth while exhibiting drastically reduced activity at all muscarinic receptor subtypes compared to scopolamine.

Comments

No comments yet.

Log in to comment